EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape

Emily Kinsey, Hannah M Lee iD

Cancers · 04.02.2024 · 16 (3) · 666

DOI: 10.3390/cancers16030666 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.02.2024. Verfasst von Emily Kinsey und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology, and Palliative Care, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA. Die Arbeit wurde bisher 135-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer is the third most common cause of cancer-related deaths worldwide, and hepatocellular carcinoma (HCC) makes up the majority of liver cancer cases. Despite the stabilization of incidence rates in recent years due to effective viral hepatitis treatments, as well as improved outcomes from early detection and treatment advances, the burden of HCC is anticipated to rise again due to increasing rates of metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease. The treatment landscape is evolving and requires a multidisciplinary approach, often involving multi-modal treatments that include surgical resection, transplantation, local regional therapies, and systemic treatments. The optimal approach to the care of the HCC patient requires a multidisciplinary team involving hepatology, medical oncology, diagnostic and interventional radiology, radiation oncology, and surgery. In order to determine which approach is best, an individualized treatment plan should consider the patient’s liver function, functional status, comorbidities, cancer stage, and preferences. In this review, we provide an overview of the current treatment options and key trials that have revolutionized the management of HCC. We also discuss evolving treatment paradigms for the future.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomaimmunotherapyliver transplantationlocoregional therapiesmultidisciplinary carepalliative care

Autor:innen und Institutionen

  • Division of Hematology, Oncology, and Palliative Care, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23219, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA 23298, USA.

ORCID-Profile: Hannah M Lee

Zitieren

APA

Kinsey, E., & Lee, H. M. (2024). Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape. Cancers, 16(3), 666. https://doi.org/10.3390/cancers16030666

Vancouver

Kinsey E, Lee HM. Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape. Cancers. 2024;16(3):666. doi:10.3390/cancers16030666

BibTeX
@article{Kinsey2024,
  author = {Kinsey, Emily and Lee, Hannah M},
  title = {Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {3},
  pages = {666},
  doi = {10.3390/cancers16030666}
}
Kostenlos starten →